bpc 157 hims BPC-157 – Alphaceuticals by Dr. Catherine Hims & Hers Stock Pops
Hims & Hers Stock Pops on FDA Panel's Peptide Recommendation Barron's HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer HIMS FDA PANEL VOTES 'YES' ON BPC 157 THE 8 PCAC PANELIST MEMBERS WHO VOTED YES: 1. Asare Christian 2. David Pope 3. Gabriel Alizaidy 4. Haleem Mohammed 5. Joshua Starbuck 6. Kris Wusterhausen 7. Melissa Loseke 8. Bobby Harshbarger BPC 157 Benefits, Dosage & Before After Results
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


